There are many risks to investing. For dividend stock investors, these risks can be divided into several areas, including these... More
- ADVERTISEMENT
-
- Poll of the Day
- Partners
- ADVERTISEMENT
JNJ
Recent Articles
3 Pharmaceuticals to Profit on Obamacare
More people enrolling in health insurance, that likely means more prescriptions and ultimately more profits for pharmaceuticals. More
3 Blue Chips Climbing on Earnings (KO, JNJ, SCHW)
Earnings season is supposed to be a dud, but don't tell that to JNJ, SCHW or KO stock, all of which got a lift from Street-beating results. More
79 Ways to Refocus Your Earnings Season Investing Strategy
Q2 earnings season is officially in full swing, and here are my takes on 79 stocks based on our Portfolio Grader system. More
5 Stocks to Buy in April
The technicals say these blue chips are stocks to buy this month thanks to price momentum and seasonal strength. Here's a closer look. More
JNJ: A Little Leaner, But Is This Dividend Stalwart a Buy?
Johnson & Johnson's Ortho-Clinical sale is a bit of a head-scratcher, but it doesn't change the big picture much. JNJ stock still serves a purpose. More
Biggest Movers in Healthcare Stocks Now – ARNA OPK UTHR ALGN
Healthcare stocks finished up 0.6% on Wall Street today. NASDAQ:ARNA, NYSE:OPK, NASDAQ:UTHR, NASDAQ:ALGN, NASDAQ:WOOF, NASDAQ:NVDQ, NYSE:LCI, NASDAQ:ACAD, NASDAQ:MYGN, NASDAQ:VOLC, NYSE:HCA, NASDAQ:MGLN, NYSE:THC, NYSE:PFE, NYSE:CAH, NYSE:AGN, NYSE:FMS, NYSE:JNJ, NYSE:MCK, NASDAQ:SHPG More
